| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 5 |
| NetGPI | no | yes: 0, no: 5 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 4 |
| GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4I061
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.551 |
| CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.655 |
| CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.551 |
| CLV_PCSK_PC1ET2_1 | 126 | 128 | PF00082 | 0.655 |
| CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.413 |
| CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.486 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.666 |
| DOC_CKS1_1 | 67 | 72 | PF01111 | 0.688 |
| DOC_PP1_RVXF_1 | 1 | 8 | PF00149 | 0.674 |
| DOC_PP4_FxxP_1 | 109 | 112 | PF00568 | 0.412 |
| DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.703 |
| DOC_WW_Pin1_4 | 66 | 71 | PF00397 | 0.660 |
| DOC_WW_Pin1_4 | 83 | 88 | PF00397 | 0.717 |
| LIG_14-3-3_CanoR_1 | 25 | 31 | PF00244 | 0.698 |
| LIG_14-3-3_CanoR_1 | 60 | 67 | PF00244 | 0.669 |
| LIG_BRCT_BRCA1_1 | 44 | 48 | PF00533 | 0.672 |
| LIG_FHA_2 | 84 | 90 | PF00498 | 0.678 |
| LIG_FHA_2 | 9 | 15 | PF00498 | 0.652 |
| LIG_RPA_C_Fungi | 55 | 67 | PF08784 | 0.515 |
| LIG_SH2_STAT5 | 116 | 119 | PF00017 | 0.527 |
| LIG_SH3_3 | 64 | 70 | PF00018 | 0.561 |
| LIG_SUMO_SIM_anti_2 | 102 | 108 | PF11976 | 0.444 |
| MOD_CDK_SPxK_1 | 66 | 72 | PF00069 | 0.606 |
| MOD_CK1_1 | 23 | 29 | PF00069 | 0.568 |
| MOD_CK1_1 | 52 | 58 | PF00069 | 0.670 |
| MOD_CK2_1 | 141 | 147 | PF00069 | 0.698 |
| MOD_CK2_1 | 83 | 89 | PF00069 | 0.590 |
| MOD_CK2_1 | 92 | 98 | PF00069 | 0.476 |
| MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.409 |
| MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.600 |
| MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.579 |
| MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.468 |
| MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.611 |
| MOD_GlcNHglycan | 98 | 102 | PF01048 | 0.415 |
| MOD_GSK3_1 | 20 | 27 | PF00069 | 0.582 |
| MOD_GSK3_1 | 36 | 43 | PF00069 | 0.684 |
| MOD_GSK3_1 | 44 | 51 | PF00069 | 0.623 |
| MOD_GSK3_1 | 92 | 99 | PF00069 | 0.559 |
| MOD_NEK2_1 | 36 | 41 | PF00069 | 0.569 |
| MOD_NEK2_1 | 42 | 47 | PF00069 | 0.535 |
| MOD_NEK2_1 | 48 | 53 | PF00069 | 0.478 |
| MOD_NEK2_2 | 20 | 25 | PF00069 | 0.584 |
| MOD_PKA_2 | 24 | 30 | PF00069 | 0.582 |
| MOD_PKA_2 | 92 | 98 | PF00069 | 0.610 |
| MOD_Plk_4 | 29 | 35 | PF00069 | 0.553 |
| MOD_Plk_4 | 99 | 105 | PF00069 | 0.462 |
| MOD_ProDKin_1 | 66 | 72 | PF00069 | 0.565 |
| MOD_ProDKin_1 | 83 | 89 | PF00069 | 0.645 |
| MOD_SUMO_rev_2 | 119 | 128 | PF00179 | 0.554 |
| MOD_SUMO_rev_2 | 144 | 152 | PF00179 | 0.676 |
| TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.696 |
| TRG_ER_diArg_1 | 80 | 83 | PF00400 | 0.651 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3Q8IFQ1 | Leishmania donovani | 100% | 100% |
| A4HCN6 | Leishmania braziliensis | 64% | 100% |
| E9ACS2 | Leishmania major | 91% | 100% |
| E9AW24 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |